The upregulation of tumour inflammasome-derived IL-1β to a certain threshold has been shown to suppress the growth of EBV-associated NPC cells by promoting an influx of neutrophils, while depletion of these neutrophils significantly diminishes the antitumour effects of IL-1β [44]. This evidence concerns the gene IL1B and nasopharyngeal carcinoma.